1-6 of 6
Authors: Jean-François Delfraissy
Journal Article
Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapy
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 9, September 2015, Pages 2627–2631, https://doi.org/10.1093/jac/dkv138
Published: 28 May 2015
Journal Article
Phenotypic characterization of virological failure following lopinavir/ritonavir monotherapy using full-length gag–protease genes
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 12, December 2014, Pages 3340–3348, https://doi.org/10.1093/jac/dku296
Published: 04 August 2014
Journal Article
Impact of 48 week lopinavir/ritonavir monotherapy on blood cell-associated HIV-1-DNA in the MONARK trial Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 5, May 2010, Pages 1005–1007, https://doi.org/10.1093/jac/dkq084
Published: 18 March 2010
Journal Article
Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 4, April 2010, Pages 741–748, https://doi.org/10.1093/jac/dkq035
Published: 18 February 2010
Journal Article
Rapid selection and archiving of mutation E157Q in HIV-1 DNA during short-term low-level replication on a raltegravir-containing regimen Get access
Journal of Antimicrobial Chemotherapy, Volume 64, Issue 2, August 2009, Pages 433–434, https://doi.org/10.1093/jac/dkp182
Published: 20 May 2009
Journal Article
Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine Get access
Journal of Antimicrobial Chemotherapy, Volume 61, Issue 6, June 2008, Pages 1344–1347, https://doi.org/10.1093/jac/dkn098
Published: 13 March 2008
